NEPHROLOGY

Dual Inhibitors: RAAS Blockers/Combination Therapies: What Do All These Trials Mean?

Oct 11, 2016 by in NEPHROLOGY Comments Off on Dual Inhibitors: RAAS Blockers/Combination Therapies: What Do All These Trials Mean?

© Springer Science+Business Media New York 2015Matthew R. Weir and Edgar V. Lerma (eds.)Chronic Kidney Disease and HypertensionClinical Hypertension and Vascular Diseases10.1007/978-1-4939-1982-6_6 6. Dual Inhibitors: RAAS Blockers/Combination Therapies: What Do All These Trials Mean? Domenic…

read more

Novel Molecules

Oct 11, 2016 by in NEPHROLOGY Comments Off on Novel Molecules

Blood pressure mechanism Antihypertensive agent Sympathetic system Human recombinant renalase Renin–angiotensin–aldosterone system Renin inhibitors  Anti-angiotensin vaccine  Angiotensin II type 2 receptor agonist  Aldosterone synthase inhibitor Natriuretic peptide system Vasopeptidase inhibitors…

read more

Which Renal Cysts Require Follow-up Evaluation?

Sep 7, 2016 by in NEPHROLOGY Comments Off on Which Renal Cysts Require Follow-up Evaluation?

Which Renal Cysts Require Follow-up Evaluation? With the ubiquitous imaging being performed today, it is very common to discover incidental renal cysts. Clinicians usually turn to nephrologists to ask what…

read more

Is Computed Tomography with Contrast or Magnetic Resonance Imaging with Contrast Preferred in Patients with Chronic Kidney Disease?

Sep 7, 2016 by in NEPHROLOGY Comments Off on Is Computed Tomography with Contrast or Magnetic Resonance Imaging with Contrast Preferred in Patients with Chronic Kidney Disease?

Is Computed Tomography with Contrast or Magnetic Resonance Imaging with Contrast Preferred in Patients with Chronic Kidney Disease? This is a clinical question that keeps coming up on nephrology rounds….

read more
Get Clinical Tree app for offline access